|
|
|
|
| LEADER |
01000cam a2200265 c4500 |
| 001 |
1180825209 |
| 003 |
DE-627 |
| 005 |
20230427151523.0 |
| 007 |
tu |
| 008 |
040407s2004 xx ||||| 00| ||eng c |
| 010 |
|
|
|a 2003044104
|
| 020 |
|
|
|a 3540406417
|9 3-540-40641-7
|
| 024 |
3 |
|
|a 9783540406419
|
| 035 |
|
|
|a (DE-627)1180825209
|
| 035 |
|
|
|a (DE-576)110825209
|
| 035 |
|
|
|a (DE-599)BSZ110825209
|
| 035 |
|
|
|a (OCoLC)314584987
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Angiotensin
|n 2 / Contributors: W. M. Aartsen ...
|c eds. Thomas Unger ...
|
| 264 |
|
1 |
|a Berlin
|a Heidelberg [u.a.]
|b Springer
|c 2004
|
| 300 |
|
|
|a XIV, 603 S.
|b Ill., graph. Darst.
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of experimental pharmacology / ed. board G. V. R. Born ...
|v 163,2
|
| 500 |
|
|
|a Includes bibliographical references and Index
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|2 pdager
|5 DE-31
|
| 650 |
|
0 |
|a Angiotensin II
|
| 650 |
|
0 |
|a Angiotensin II
|x physiology
|
| 650 |
|
0 |
|a Angiotensin-Converting Enzyme Inhibitors
|x pharmacokinetics
|
| 650 |
|
0 |
|a Renin-Angiotensin System
|x physiology
|
| 773 |
1 |
8 |
|w (DE-627)1180812883
|w (DE-576)110812883
|g 2
|q 2
|7 nnnm
|
| 830 |
|
0 |
|a Handbook of experimental pharmacology
|v 163,2
|9 163,2
|w (DE-627)1081606150
|w (DE-576)011606150
|7 ns
|
| 856 |
4 |
2 |
|u https://swbplus.bsz-bw.de/bsz110825209inh.htm
|m V:DE-576
|q text/html
|3 Inhaltsverzeichnis
|
| 856 |
4 |
2 |
|u https://swbplus.bsz-bw.de/bsz110825209kap.htm
|m V:DE-576
|q text/html
|3 Kapitel 1
|
| 856 |
4 |
2 |
|u https://swbplus.bsz-bw.de/bsz110825209cov.jpg
|m V:DE-576
|q text/html
|3 Cover
|
| 912 |
|
|
|a GBV_ILN_2002
|
| 912 |
|
|
|a ISIL_DE-21-3
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_2004
|
| 912 |
|
|
|a ISIL_DE-25-73
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a ISIL_DE-291M
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a ISIL_DE-14
|
| 912 |
|
|
|a GBV_ILN_2007
|
| 912 |
|
|
|a ISIL_DE-352
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a ISIL_DE-24
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a ISIL_DE-15-292
|
| 912 |
|
|
|a GBV_ILN_2011
|
| 912 |
|
|
|a ISIL_DE-16
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 912 |
|
|
|a ISIL_DE-31
|
| 912 |
|
|
|a GBV_ILN_2141
|
| 912 |
|
|
|a ISIL_DE-16-300
|
| 935 |
|
|
|h SWB
|i 4165
|
| 951 |
|
|
|a MV
|
| 980 |
|
|
|2 2002
|1 01
|x DE-21-3
|b 2588527396
|c 00
|f --%%--
|d R S 163/2
|e p
|j --%%--
|y l01
|z 23-12-08
|
| 980 |
|
|
|2 2004
|1 01
|x DE-25-73
|b 276991832X
|c 00
|f --%%--
|d Frei 73: A 5-163,2
|e p
|j --%%--
|y l01
|z 21-10-13
|
| 980 |
|
|
|2 2005
|1 01
|x DE-291M
|b 2441166727
|c 00
|f --%%--
|d Pha Hb 1 163,2
|e --%%--
|j --%%--
|k Pharmakologie
|y l01
|z 21-07-05
|
| 980 |
|
|
|2 2006
|1 01
|x DE-14
|b 244116662X
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 30-04-04
|
| 980 |
|
|
|2 2007
|1 01
|x DE-352
|b 2441166697
|c 00
|f --%%--
|d bch 540:mb/e42-163,2
|e --%%--
|j --%%--
|y l01
|z 08-07-04
|
| 980 |
|
|
|2 2008
|1 01
|x DE-24
|b 2441166719
|c 00
|f --%%--
|d 54/10963-2
|e --%%--
|j --%%--
|k bo BP
|y l01
|z 06-08-04
|
| 980 |
|
|
|2 2010
|1 01
|x DE-15-292
|b 2441166700
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|y l01
|z 13-07-04
|
| 980 |
|
|
|2 2011
|1 01
|x DE-16
|b 2441166662
|c 00
|f --%%--
|d UBN/XI 1701 H236-163
|e --%%--
|j --%%--
|y l01
|z 19-04-04
|
| 980 |
|
|
|2 2018
|1 01
|x DE-31
|b 2441166689
|c 00
|f --%%--
|d 109 A 271,163,2
|e --%%--
|j --%%--
|y l01
|z 27-08-04
|
| 980 |
|
|
|2 2141
|1 01
|x DE-16-300
|b 2441166646
|c 00
|f --%%--
|d P 1a
|e --%%--
|j --%%--
|y l01
|z 03-05-04
|
| 985 |
|
|
|2 2002
|1 01
|x DE-21-3
|a 711
|
